Unicycive Therapeutics (UNCY)
NASDAQ:UNCY
US Market
Holding UNCY?
Track your performance easily

Unicycive Therapeutics (UNCY) Cash flow

274 Followers

Unicycive Therapeutics Cash Flow

UNCY's free cash flow for Q2 2024 was $-6.34M. For the 2024 fiscal year, UNCY's free cash flow was decreased by $-2.64M and operating cash flow was $-6.32M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -21.64M$ -18.28M$ -15.65M$ -5.77M$ -1.46M$ -1.18M
Investing Cash Flow
$ -26.00K$ -12.00K$ -2.00K$ -29.00K$ 0.00-
Financing Cash Flow
$ 44.62M$ 27.54M$ -471.00K$ 22.38M$ 1.44M$ 1.17M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 114.76M$ 9.70M$ 455.00K$ 16.58M$ 0.00$ 15.00K
Income Tax Paid Supplemental Data
----$ 1.00K$ 2.00K
Interest Paid Supplemental Data
$ 60.00K$ 24.00K----
Issuance Of Capital Stock
$ -1.66M-$ 11.00K$ 22.27M$ 141.00K$ 1.17M
Issuance Of Debt
$ -752.00K$ -496.00K$ -482.00K$ -15.00K$ 1.58M$ 9.00K
Repayment Of Debt
$ -752.00K$ -496.00K$ -482.00K$ -1.36M$ -160.00K$ -9.00K
Free Cash Flow
$ -21.66M$ -18.30M$ -15.65M$ -5.80M$ -1.46M$ -1.18M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Unicycive Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis